No Data
No Data
K PHARMA: Financial results presentation for the 1st quarter of the fiscal year ending 2024/12
K PHARMA: Confirmation
K PHARMA: Quarterly Report - Eighth Quarter 1 (2024/01/01 - 2024/03/31)
K PHARMA: Consolidated Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Unconsolidated)
Taiseiken, Obayashi Corporation, Toray, Shiono Yoshi (13th) (1417-5070)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/13 (Mon) <1417>Miraite One <1435>Robohome<146A>Colombia <1515>Nippon Steel Mining <1518>Mitsui Matsushima HD <1663>K&O Energy<167A>Ryosan Ryoyo <1736>Autech <174
King Jim, etc. [Next week's purchase demand]
[Next Week's Purchase Demand (table)] Code; Stock Price Impact; Buy Demand; Credit Ratio; Closing Price; Price Ratio; Previous Day Ratio <2196>; ESCRI; 410%; 110400; 3.57; 291; -1 <4896>; K Pharma; 333%; 6000; 11.86; 640; -8 <7962>; King Jim; 161%; 21900; 0.06; 890; 0 <7816>; Snow Peak; 132%; 29500; 1.80; 1246; 2 < 2 < 3547>; Kushikatsuda
No Data